of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines.
Along with CP, other FQ derivatives like ofloxacin, levofloxacin, enoxacin and fleroxacin were shown to inhibit the growth of transitional cell and bladder carcinoma cell lines. 2 CP enhanced the antiproliferative effect of 5-fluorouracil 12 , used for treatment of colon cancer. 13 FQs inhibit the activity of mammalian DNA topoisomerases I, II and DNA polymerase enzymes involved in supercoiling, transcription, replication and chromosomal separation of prokaryotic DNA. 5, 14 Many reports indicate, antitumor efficacy of FQs can be augmented by increasing the lipophilicity of compounds. 2, 15, 16 Introducing substituents at C-7 position of camptothecin improved the lipophilicity and this led to the discovery of gimatecan, which is currently in phase II clinical trials. 17 In bis-quinolinium compounds, lipophilicity of the substituent enhanced their antiproliferative activity against HT-29 colon cancer cell line. 18 Structure of FQ derivatives as anticancer agents is depicted in figure 1. [19] [20] [21] CP showed antiproliferative and apoptotic activities on prostate cancer cell lines (PC3) but not on non-tumorigenic prostate epithelial cells (MLC8891). 22 CP can impede the acute and chronic prostate inflammation which is responsible for prostate cancer development. 23 Fruitful anticancer results of lipophilic derivatives of CP have attracted us to investigate new lipophilic derivatives of CP as antitumor agents. Hence, we impelled our research work and synthesized new FQ derivatives as antitumor agents. In the current study, we synthesized 7-(substituted piperazin-1-yl) derivatives of CP. Firstly, 7-(4-(2-chloroacetyl)piperazin-1-yl)-1-cyclopropyl-6fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid(2)was synthesized by coupling CP with chloroacetyl chloride as reported earlier 2 and then various substituted piperazines were reacted with 2 to enhance the lipophilicity (Scheme 1).
Acylation of CP, 1 with chloroacetyl chloride in CH 2 Cl 2 yielded compound 2 in 70% after purification. 2 The series of 1-cyclopropyl-6-fluoro-4-oxo-7-(4-substituted piperazin-1-yl)-1,4dihydro quinoline-3-carboxylic acid derivativesof CP were prepared by coupling commercially available substituted piperazines with 2 in N,N-dimethylformamide (DMF) to obtain the final compounds 3a-v in yields ranging from 55-95%. 24 (Scheme 1, Table 1) The synthesized compounds were evaluated for their inhibitory activity on the proliferation [23] Kloskowski, T.; Gurtowska, N.; Bajek, A.; Drewa, T.Med. Hypotheses. 2012, 78, 235.
[24] Synthesis of 1-cyclopropyl-6-fluoro-7-[4-(2- = 3.7 Hz), 53.67, 51.12, 50.89, 49.16, 45.91, 41.39, 35.58, 8.12 aqueous solution was added. The plate was returned to the incubator for 1 h in a humidified atmosphere at 37 °C. The absorbance of the formazan product was measured at 490 nm using microplate reader. The blank control was recorded by measuring the absorbance at 490 nm with wells containing medium mixed with CellTiter 96 aqueous solution but no cells. Results were expressed as the percentage of the control (without compound set at 100%).
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3.Physical and spectral data for 3b-v 7-[4-(2-{4-(4-chlorophenyl) piperazin-1-yl}acetyl)piperazin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo-1,4dihydroquinoline-3-carboxylic = 3.7 Hz), 53.89, 51.12, 50.46, 49.12, 45.84, 35.82, 8.43 7-[4-(2-{4-acetylpiperazin-1-yl}acetyl) piperazin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo-1,4dihydroquinoline-3-carboxylic acid (3c) 7-[4-(2-{4-benzylpiperazin-1-yl}acetyl) piperazin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo-1,4dihydroquinoline-3-carboxylic acid (3d) 1-cyclopropyl-6-fluoro-4-oxo-7-[4-(2-{4-phenylpiperazin-1-yl}acetyl) 7-[4-(2-{4-(2-chlorophenyl) piperazin-1-yl}acetyl)piperazin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo-1,4dihydroquinoline-3-carboxylic 139.01, 130.95, 129.13, 128.64, 124.2, 122.26, 120.15 (d 11, 51.75, 50.83, 48.96, 44.72, 35.42, 7.87 
